1-13 of 13
Monica M. Bertagnolli
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A013: CDK2 and CDK4/6 inhibition in GIST: Mechanisms of response and resistance

Inga-Marie Schaefer, Matthew L. Hemming, Meijun Z. Lundberg, Matthew P. Serrata, Isabel Goldaracena, Ninning Liu, Peng Yin, Joao A. Paulo, Steven P. Gygi, Suzanne George, Jeffrey A. Morgan, Monica M. Bertagnolli, Ewa T. Sicinska, Adrian Mariño-Enríquez, Jason L. Hornick, Chandrajit P. Raut, George D. Demetri, Wen-Bin Ou, Sinem K. Saka, Jonathan A. Fletcher
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (18_Supplement): A013.
https://doi.org/10.1158/1557-3265.SARCOMAS22-A013
Published: 15 September 2022
View articletitled, Abstract A013: CDK2 and CDK4/6 inhibition in GIST: Mechanisms of response and resistance
Journal Articles

Linking Genotype to Phenotype: Bench to Bedside

Suzanne George, Monica M. Bertagnolli
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (13): 2725–2727.
https://doi.org/10.1158/1078-0432.CCR-22-0027
Published: 01 July 2022
View articletitled, Linking Genotype to Phenotype: Bench to Bedside
Open the PDF for Linking Genotype to Phenotype: Bench to Bedside in another window
Journal Articles

Tumor Immunogenomic Features Determine Outcomes in Patients with Metastatic Colorectal Cancer Treated with Standard-of-Care Combinations of Bevacizumab and Cetuximab

Federico Innocenti, Akram Yazdani, Naim Rashid, Xueping Qu, Fang-Shu Ou, Scott Van Buren, Monica M. Bertagnolli, Omar Kabbarah, Charles David Blanke, Alan P. Venook, Heinz-Josef Lenz, Benjamin G. Vincent
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (8): 1690–1700.
https://doi.org/10.1158/1078-0432.CCR-21-3202
Published: 14 April 2022
View articletitled, Tumor Immunogenomic Features Determine Outcomes in Patients with Metastatic Colorectal Cancer Treated with Standard-of-Care Combinations of Bevacizumab and Cetuximab
Open the PDF for Tumor Immunogenomic Features Determine Outcomes in Patients with Metastatic Colorectal Cancer Treated with Standard-of-Care Combinations of Bevacizumab and Cetuximab in another window
Includes: Supplementary data
Journal Articles

Genomic Analysis of Germline Variation Associated with Survival of Patients with Colorectal Cancer Treated with Chemotherapy Plus Biologics in CALGB/SWOG 80405 (Alliance)

Federico Innocenti, Alexander B. Sibley, Sushant A. Patil, Amy S. Etheridge, Chen Jiang, Fang-Shu Ou, Stefanie D. Howell, Sarah J. Plummer, Graham Casey, Monica M. Bertagnolli, Howard L. McLeod, James T. Auman, Charles D. Blanke, Yoichi Furukawa, Alan P. Venook, Michiaki Kubo, Heinz-Josef Lenz, Joel S. Parker, Mark J. Ratain, Kouros Owzar
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (1): 267–275.
https://doi.org/10.1158/1078-0432.CCR-20-2021
Published: 04 January 2021
View articletitled, Genomic Analysis of Germline Variation Associated with Survival of Patients with Colorectal Cancer Treated with Chemotherapy Plus Biologics in CALGB/SWOG 80405 (Alliance)
Open the PDF for Genomic Analysis of Germline Variation Associated with Survival of Patients with Colorectal Cancer Treated with Chemotherapy Plus Biologics in CALGB/SWOG 80405 (Alliance) in another window
Includes: Supplementary data
Journal Articles

Prognostic and Predictive Blood-Based Biomarkers in Patients with Advanced Pancreatic Cancer: Results from CALGB80303 (Alliance)

Andrew B. Nixon, Herbert Pang, Mark D. Starr, Paula N. Friedman, Monica M. Bertagnolli, Hedy L. Kindler, Richard M. Goldberg, Alan P. Venook, Herbert I. Hurwitz, for the Alliance for Clinical Trials In Oncology
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (24): 6957–6966.
https://doi.org/10.1158/1078-0432.CCR-13-0926
Published: 16 December 2013
View articletitled, Prognostic and Predictive Blood-Based Biomarkers in Patients with Advanced Pancreatic Cancer: Results from CALGB80303 (Alliance)
Open the PDF for Prognostic and Predictive Blood-Based Biomarkers in Patients with Advanced Pancreatic Cancer: Results from CALGB80303 (Alliance) in another window
Journal Articles

Germline Variants and Advanced Colorectal Adenomas: Adenoma Prevention with Celecoxib Trial Genome-wide Association Study

Jiping Wang, Luis G. Carvajal-Carmona, Jen-Hwa Chu, Ann G. Zauber, APC Trial Collaborators, Michikai Kubo, Koichi Matsuda, Malcolm Dunlop, Richard S. Houlston, Oliver Sieber, Lara Lipton, Peter Gibbs, Nicholas G. Martin, Grant W. Montgomery, Joanne Young, Paul N. Baird, Mark J. Ratain, Yusuke Nakamura, Scott T. Weiss, Ian Tomlinson, Monica M. Bertagnolli
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (23): 6430–6437.
https://doi.org/10.1158/1078-0432.CCR-13-0550
Published: 01 December 2013
View articletitled, Germline Variants and Advanced Colorectal Adenomas: Adenoma Prevention with Celecoxib Trial Genome-wide Association Study
Open the PDF for Germline Variants and Advanced Colorectal Adenomas: Adenoma Prevention with Celecoxib Trial Genome-wide Association Study in another window
Includes: Supplementary data
Journal Articles

Association of TP53 Mutational Status and Gender with Survival after Adjuvant Treatment for Stage III Colon Cancer: Results of CALGB 89803

Robert S. Warren, Chloe E. Atreya, Donna Niedzwiecki, Vivian K. Weinberg, David B. Donner, Robert J. Mayer, Richard M. Goldberg, Carolyn C. Compton, Marlene B. Zuraek, Cynthia Ye, Leonard B. Saltz, Monica M. Bertagnolli
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (20): 5777–5787.
https://doi.org/10.1158/1078-0432.CCR-13-0351
Published: 14 October 2013
View articletitled, Association of TP53 Mutational Status and Gender with Survival after Adjuvant Treatment for Stage III Colon Cancer: Results of CALGB 89803
Open the PDF for Association of TP53 Mutational Status and Gender with Survival after Adjuvant Treatment for Stage III Colon Cancer: Results of CALGB 89803 in another window
Includes: Supplementary data
Journal Articles

Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803

Shuji Ogino, Kaori Shima, Jeffrey A. Meyerhardt, Nadine J. McCleary, Kimmie Ng, Donna Hollis, Leonard B. Saltz, Robert J. Mayer, Paul Schaefer, Renaud Whittom, Alexander Hantel, Al B. Benson, III, Donna Spiegelman, Richard M. Goldberg, Monica M. Bertagnolli, Charles S. Fuchs
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (3): 890–900.
https://doi.org/10.1158/1078-0432.CCR-11-2246
Published: 31 January 2012
View articletitled, Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803
Open the PDF for Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803 in another window
Includes: Supplementary data
Journal Articles

KRAS Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803

Shuji Ogino, Jeffrey A. Meyerhardt, Natsumi Irahara, Donna Niedzwiecki, Donna Hollis, Leonard B. Saltz, Robert J. Mayer, Paul Schaefer, Renaud Whittom, Alexander Hantel, Al B. Benson, III, Richard M. Goldberg, Monica M. Bertagnolli, Charles S. Fuchs, for the Cancer and Leukemia Group B, North Central Cancer Treatment Group, Canadian Cancer Society Research Institute, Southwest Oncology Group
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (23): 7322–7329.
https://doi.org/10.1158/1078-0432.CCR-09-1570
Published: 30 November 2009
View articletitled, KRAS Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803
Open the PDF for KRAS Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803 in another window
Journal Articles

p27Kip1 in Stage III Colon Cancer: Implications for Outcome following Adjuvant Chemotherapy in Cancer and Leukemia Group B Protocol 89803

Monica M. Bertagnolli, Robert S. Warren, Donna Niedzwiecki, Elke Mueller, Carolyn C. Compton, Mark Redston, Margaret Hall, Hejin P. Hahn, Scott D. Jewell, Robert J. Mayer, Richard M. Goldberg, Leonard B. Saltz, Massimo Loda
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (6): 2116–2122.
https://doi.org/10.1158/1078-0432.CCR-08-2674
Published: 16 March 2009
View articletitled, p27Kip1 in Stage III Colon Cancer: Implications for Outcome following Adjuvant Chemotherapy in Cancer and Leukemia Group B Protocol 89803
Open the PDF for p27Kip1 in Stage III Colon Cancer: Implications for Outcome following Adjuvant Chemotherapy in Cancer and Leukemia Group B Protocol 89803 in another window
Journal Articles

Radioimmunotherapy for Colorectal Cancer

Monica M. Bertagnolli
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (13): 4637–4638.
https://doi.org/10.1158/1078-0432.CCR-05-0485
Published: 06 July 2005
View articletitled, Radioimmunotherapy for Colorectal Cancer
Open the PDF for Radioimmunotherapy for Colorectal Cancer in another window
Journal Articles

Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development : Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia

Joyce A. O’Shaughnessy, Gary J. Kelloff, Gary B. Gordon, Andrew J. Dannenberg, Waun Ki Hong, Carol J. Fabian, Caroline C. Sigman, Monica M. Bertagnolli, Steven P. Stratton, Stephen Lam, William G. Nelson, Frank L. Meyskens, David S. Alberts, Michele Follen, Anil K. Rustgi, Vali Papadimitrakopoulou, Peter T. Scardino, Adi F. Gazdar, Lee W. Wattenberg, Michael B. Sporn, Wael A. Sakr, Scott M. Lippman, Daniel D. Von Hoff
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (2): 314–346.
Published: 01 February 2002
View articletitled, Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development : Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia
Open the PDF for Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development : Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia in another window
Journal Articles

Colon Cancer Chemopreventive Drugs Modulate Integrin-mediated Signaling Pathways

Michael J. Weyant, Adelaide M. Carothers, Maria E. Bertagnolli, Monica M. Bertagnolli
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (3): 949–956.
Published: 01 March 2000
View articletitled, Colon Cancer Chemopreventive Drugs Modulate Integrin-mediated Signaling Pathways
Open the PDF for Colon Cancer Chemopreventive Drugs Modulate Integrin-mediated Signaling Pathways in another window